338 related articles for article (PubMed ID: 22851573)
1. The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment.
Xu J; Wu W; Zhang L; Dorset-Martin W; Morris MW; Mitchell ME; Liechty KW
Diabetes; 2012 Nov; 61(11):2906-12. PubMed ID: 22851573
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-146a Deficiency Delays Wound Healing in Normal and Diabetic Mice.
Bi X; Zhou L; Liu Y; Gu J; Mi QS
Adv Wound Care (New Rochelle); 2022 Jan; 11(1):19-27. PubMed ID: 33554730
[No Abstract] [Full Text] [Related]
3. The role of microRNA-15b in the impaired angiogenesis in diabetic wounds.
Xu J; Zgheib C; Hu J; Wu W; Zhang L; Liechty KW
Wound Repair Regen; 2014; 22(5):671-7. PubMed ID: 25059098
[TBL] [Abstract][Full Text] [Related]
4. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.
Ramkaran P; Khan S; Phulukdaree A; Moodley D; Chuturgoon AA
Cell Biochem Biophys; 2014 Mar; 68(2):259-66. PubMed ID: 23794009
[TBL] [Abstract][Full Text] [Related]
5. The bone mesenchymal stem cell-derived exosomal miR-146a-5p promotes diabetic wound healing in mice via macrophage M1/M2 polarization.
Zhou X; Ye C; Jiang L; Zhu X; Zhou F; Xia M; Chen Y
Mol Cell Endocrinol; 2024 Jan; 579():112089. PubMed ID: 37863468
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-146a-5p Negatively Regulates Pro-Inflammatory Cytokine Secretion and Cell Activation in Lipopolysaccharide Stimulated Human Hepatic Stellate Cells through Inhibition of Toll-Like Receptor 4 Signaling Pathways.
Chen Y; Zeng Z; Shen X; Wu Z; Dong Y; Cheng JC
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399683
[TBL] [Abstract][Full Text] [Related]
7. Use of Cerium Oxide Nanoparticles Conjugated with MicroRNA-146a to Correct the Diabetic Wound Healing Impairment.
Zgheib C; Hilton SA; Dewberry LC; Hodges MM; Ghatak S; Xu J; Singh S; Roy S; Sen CK; Seal S; Liechty KW
J Am Coll Surg; 2019 Jan; 228(1):107-115. PubMed ID: 30359833
[TBL] [Abstract][Full Text] [Related]
8. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes.
Feng B; Chen S; Gordon AD; Chakrabarti S
J Mol Cell Cardiol; 2017 Apr; 105():70-76. PubMed ID: 28279663
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.
Lv F; Huang Y; Lv W; Yang L; Li F; Fan J; Sun J
Med Sci Monit; 2017 Feb; 23():659-664. PubMed ID: 28161709
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.
Chan YC; Roy S; Khanna S; Sen CK
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1372-82. PubMed ID: 22499991
[TBL] [Abstract][Full Text] [Related]
11. The role of miR-146a on NF-κB expression level in human umbilical vein endothelial cells under hyperglycemic condition.
Kamali K; Korjan ES; Eftekhar E; Malekzadeh K; Soufi FG
Bratisl Lek Listy; 2016; 117(7):376-80. PubMed ID: 27546538
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
[TBL] [Abstract][Full Text] [Related]
13. The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy.
Wang L; Chopp M; Szalad A; Zhang Y; Wang X; Zhang RL; Liu XS; Jia L; Zhang ZG
Neuroscience; 2014 Feb; 259():155-63. PubMed ID: 24316060
[TBL] [Abstract][Full Text] [Related]
14. A Synthetic Curcuminoid Analog, (2
Huang J; Fu J; Liu B; Wang R; You T
Molecules; 2020 Feb; 25(4):. PubMed ID: 32092902
[TBL] [Abstract][Full Text] [Related]
15. miR-146a promotes M2 macrophage polarization and accelerates diabetic wound healing by inhibiting the TLR4/NF-κB axis.
Peng X; He F; Mao Y; Lin Y; Fang J; Chen Y; Sun Z; Zhuo Y; Jiang J
J Mol Endocrinol; 2022 May; 69(2):315-327. PubMed ID: 35604113
[TBL] [Abstract][Full Text] [Related]
16. Thymosin β4 up-regulation of microRNA-146a promotes oligodendrocyte differentiation and suppression of the Toll-like proinflammatory pathway.
Santra M; Zhang ZG; Yang J; Santra S; Santra S; Chopp M; Morris DC
J Biol Chem; 2014 Jul; 289(28):19508-18. PubMed ID: 24828499
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells-derived MFG-E8 accelerates diabetic cutaneous wound healing.
Uchiyama A; Motegi SI; Sekiguchi A; Fujiwara C; Perera B; Ogino S; Yokoyama Y; Ishikawa O
J Dermatol Sci; 2017 Jun; 86(3):187-197. PubMed ID: 28302404
[TBL] [Abstract][Full Text] [Related]
18. Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas.
Winkler MA; Dib C; Ljubimov AV; Saghizadeh M
PLoS One; 2014; 9(12):e114692. PubMed ID: 25490205
[TBL] [Abstract][Full Text] [Related]
19. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis.
Xu J; Zgheib C; Hodges MM; Caskey RC; Hu J; Liechty KW
Physiol Genomics; 2017 Oct; 49(10):541-548. PubMed ID: 28842435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
